b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1564392/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564392/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Virology Journal" /><meta name="citation_title" content="Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay" /><meta name="citation_authors" content="Mark E Shaneyfelt, Anna D Burke, Joel W Graff, Mark A Jutila, Michele E Hardy" /><meta name="citation_date" content="2006" /><meta name="citation_volume" content="3" /><meta name="citation_doi" content="10.1186/1743-422X-3-68" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1564392/?report=abstract" /><meta name="citation_pmid" content="16948846" /><meta name="DC.Title" content="Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Mark E Shaneyfelt" /><meta name="DC.Contributor" content="Anna D Burke" /><meta name="DC.Contributor" content="Joel W Graff" /><meta name="DC.Contributor" content="Mark A Jutila" /><meta name="DC.Contributor" content="Michele E Hardy" /><meta name="DC.Date" content="2006" /><meta name="DC.Identifier" content="10.1186/1743-422X-3-68" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay" /><meta property="og:type" content="article" /><meta property="og:description" content="There is widespread interest in the use of innate immune modulators as a defense strategy against infectious pathogens. Using rotavirus as a model system, we developed a cell-based, moderate-throughput screening (MTS) assay to identify compounds that ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564392/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1564392/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1564392/pdf/12985_2006_Article_175.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1B9739E99A76110000000003970397.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC1564392</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">Virology Journal</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Virol J</span>. 2006; 3: 68. </span></div><div><span class="fm-vol-iss-date">Published online 2006 Sep 1. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1743-422X-3-68" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1743-422X-3-68</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1564392</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/16948846">16948846</a></div></div></div></div><h1 class="content-title">Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Shaneyfelt%20ME%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16948846" class="affpopup" co-rid="_co_idm140544291841056" co-class="co-affbox">Mark E Shaneyfelt</a>,<sup></sup> <a href="/pubmed/?term=Burke%20AD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16948846" class="affpopup" co-rid="_co_idm140544219520208" co-class="co-affbox">Anna D Burke</a>,<sup></sup> <a href="/pubmed/?term=Graff%20JW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16948846" class="affpopup" co-rid="_co_idm140544219929792" co-class="co-affbox">Joel W Graff</a>,<sup></sup> <a href="/pubmed/?term=Jutila%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16948846" class="affpopup" co-rid="_co_idm140544219177520" co-class="co-affbox">Mark A Jutila</a>,<sup></sup> and  <a href="/pubmed/?term=Hardy%20ME%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16948846" class="affpopup" co-rid="_co_idm140544215739648" co-class="co-affbox">Michele E Hardy</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140544291841056"><h3 class="no_margin">Mark E Shaneyfelt</h3><p>Veterinary Molecular Biology, Montana State University, Bozeman, MT 59715 USA </p><div>Find articles by <a href="/pubmed/?term=Shaneyfelt%20ME%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16948846">Mark E Shaneyfelt</a></div></div><div id="_co_idm140544219520208"><h3 class="no_margin">Anna D Burke</h3><p>Veterinary Molecular Biology, Montana State University, Bozeman, MT 59715 USA </p><div>Find articles by <a href="/pubmed/?term=Burke%20AD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16948846">Anna D Burke</a></div></div><div id="_co_idm140544219929792"><h3 class="no_margin">Joel W Graff</h3><p>Veterinary Molecular Biology, Montana State University, Bozeman, MT 59715 USA </p><div>Find articles by <a href="/pubmed/?term=Graff%20JW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16948846">Joel W Graff</a></div></div><div id="_co_idm140544219177520"><h3 class="no_margin">Mark A Jutila</h3><p>Veterinary Molecular Biology, Montana State University, Bozeman, MT 59715 USA </p><div>Find articles by <a href="/pubmed/?term=Jutila%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16948846">Mark A Jutila</a></div></div><div id="_co_idm140544215739648"><h3 class="no_margin">Michele E Hardy</h3><p>Veterinary Molecular Biology, Montana State University, Bozeman, MT 59715 USA </p><div>Find articles by <a href="/pubmed/?term=Hardy%20ME%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16948846">Michele E Hardy</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140544216914288_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140544216914288_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140544216914288_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140544216914288_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1">Veterinary Molecular Biology, Montana State University, Bozeman, MT 59715 USA </div><div><span class="fm-affl">Mark E Shaneyfelt, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.agaznog@fyenahsm" class="oemail">ude.agaznog@fyenahsm</a></span>.</div><div><a href="#idm140544216914288aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140544216914288_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2006 Jun 22; Accepted 2006 Sep 1.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140544216914288_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Shaneyfelt et al; licensee BioMed Central Ltd. 2006</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1564392/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">There is widespread interest in the use of innate immune modulators as a defense strategy against infectious pathogens. Using rotavirus as a model system, we developed a cell-based, moderate-throughput screening (MTS) assay to identify compounds that reduce rotavirus infectivity in vitro, toward a long-term goal of discovering immunomodulatory agents that enhance innate responses to viral infection.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Results</h3><p id="__p2" class="p p-first-last">A natural product library consisting of 280 compounds was screened in the assay and 15 compounds that significantly reduced infectivity without cytotoxicity were identified. Time course analysis of four compounds with previously characterized effects on inflammatory gene expression inhibited replication with pre-treatment times as minimal as 2 hours. Two of these four compounds, &#x003b1;-mangostin and 18-&#x003b2;-glycyrrhetinic acid, activated NF&#x003ba;B and induced IL-8 secretion. The assay is adaptable to other virus systems, and amenable to full automation and adaptation to a high-throughput format.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Conclusion</h3><p id="__p3" class="p p-first-last">Identification of several compounds with known effects on inflammatory and antiviral gene expression that confer resistance to rotavirus infection in vitro suggests the assay is an appropriate platform for discovery of compounds with potential to amplify innate antiviral responses.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Electronic supplementary material</h3><p id="__p4" class="p p-first-last">The online version of this article (doi:10.1186/1743-422X-3-68) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Abietic Acid, Focus Form Unit, Natural Product Library, Innate Immune Signaling Pathway, Immune Potentiator</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="__p5" class="p p-first">Interest in the use of innate immune modulating agents recently has increased in the context of developing effective biodefense strategies. Increasing natural disease resistance by administration of agonists that stimulate pathogen recognition receptors and gene expression pathways is an approach that would provide broad protection from infection without need for pathogen-specific vaccines. Stimulating broadly reactive immune responses to viral, as well as bacterial and protozoan pathogens, has shown efficacy in animal models and is the subject of recent reviews that address the utility of immune potentiators in developing infectious disease defense strategies [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_849723658">1</a>, <a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713398">2</a>]. The number of such compounds currently in clinical development lends support for this approach [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_849723656">3</a>].</p><p id="__p6">To be seriously considered as a candidate antiviral drug or innate immune agonist, rapid and quantitative assessment of activity and toxicity in cell culture are prerequisite to lead compound development [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713409">4</a>]. Therefore, development of screening assays in cell lines that can simultaneously support virus replication and be responsive to measures of inhibition of virus replication are a priority. Cell-based high-throughput screening (HTS) assays that test for compounds active against hepatitis C virus (HCV), HIV and SARS coronavirus utilize recombinant viruses and changes in reporter gene expression in engineered cell lines to measure antiviral activity [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713403">5</a>&#x02013;<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_849723657">8</a>]. For example, a dual replicon assay system that combined reporter gene assays and FRET was used to screen for drugs effective against HCV [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713404">5</a>]. Advantages of these cited assays include rapid readout and an ability to perform screens with viruses that must be handled under elevated biosafety conditions.</p><p id="__p7">The intent of the studies reported here was to establish a cell-based screening assay that could identify compounds that inhibit virus replication by inducing antiviral gene expression pathways. Although the assay could identify compounds that target distinct steps of the virus replication cycle, we are interested in those that stimulate cellular responses necessary to confer initial resistance to rotavirus infection. The theory behind this approach is that amplification of the antiviral response will override virus-encoded immune evasion strategies and restrict replication to subclinical levels.</p><p id="__p8" class="p p-last">Rotaviruses are responsible for the majority of childhood morbidity and mortality from viral gastroenteritis [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713412">9</a>]. Several rotavirus vaccines in clinical trials show promising efficacy, suggesting that a long-term goal of rotavirus gastroenteritis becoming a vaccine preventable disease is attainable [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713416">10</a>]. However, the significant mortality associated with rotavirus illness in the developing world suggests approaches to enhance the antiviral immune response and consequent natural resistance to rotavirus infection need to be explored. The importance of this issue and the significant amount of data available on rotavirus replication led us to use this virus as a model system. We report development of an assay that uses unmodified adherent epithelial cells to measure reductions in rotavirus infectivity in response to treatment of cells with a variety of compounds. A natural product library consisting of 280 compounds derived from plant extracts was screened, and several compounds that inhibited rotavirus infectivity in a dose-dependent manner were identified. All of the compounds that passed the designated criteria of a hit have been reported to have direct effects on inflammatory or antiviral gene expression or on virus replication. Development of such a platform to screen compounds for the ability to diminish virus replication easily can be applied to other virus systems where direct measurement of activity in epithelial cells is desirable.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Results</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Screening assay development</h3><p id="__p9" class="p p-first">An ELISA-based assay that successfully measured neutralization of rotavirus infectivity has been reported [<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713397">11</a>]. Similarly, we adapted an immunofluorescent (IF) infectivity assay to a moderate-throughput screening (MTS) format to measure changes in rotavirus infectivity following treatment of cells with compounds from a natural product library. In the standard IF assay, MA104 cells are cultured to confluence in 96-well microtiter plates, then infected with rotavirus in triplicate wells and incubated for 18&#x02013;20 hours. Virus replication then is detected by indirect IF and replication is quantified by counting fluorescent focus forming units (FFU) in a dilution series by fluorescence microscopy. To adapt the assay to an MTS format that would necessarily eliminate manual counting of FFU, an HRP-conjugated secondary antibody was used in place of the FITC-conjugated antibody, and the assay was developed with chemiluminescent substrate. Virus replication then was quantified in a microplate fluorometer with readout of relative light units (rlu). Use of an enzymatic signal to measure infectivity was validated by comparing changes in chemiluminescent signal versus virus dose measured by IF. The data shown in figure <a href="/pmc/articles/PMC1564392/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">figure1</span></span><span>1</span></a> illustrate the range of increase in chemiluminescent signal that corresponds with increasing infectious units in a 10<sup>-1/3</sup> virus dilution series. These data demonstrate that changes in the magnitude of the enzymatic signal accurately reflect changes in the number of infectious units measured by IF.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC1564392/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140544219160176" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig1_HTML.jpg" src="/pmc/articles/PMC1564392/bin/12985_2006_Article_175_Fig1_HTML.jpg" /></div><div id="largeobj_idm140544219160176" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1564392/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC1564392/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p10"><strong>Luminescent signal magnitude corresponds with infectious units</strong>. Cells were infected with 10<sup>-1/3</sup> serial dilutions of rotavirus for 18 hours. Plates were fixed and probed with anti-VP6 mAb A6M followed by peroxidase-conjugated goat anti-mouse IgG. Signals were developed with chemiluminescent substrate and measured on a ThermoElectron Fluroskan and scored as relative light units (rlu). Error bars are standard errors of the means (n = 5).</p></div></div></div><p id="__p11" class="p p-last">In order to establish internal inhibition controls for the assay, we measured reductions in infectivity in response to cytokines known to induce antiviral gene expression. Cells were pre-treated with IFN&#x003b1;, IFN&#x003b3;, or a combination of both cytokines. IFN&#x003b1; and IFN&#x003b3; both reduced infectivity, and the magnitude of reduction increased to ~80% when cells were treated with the combination of both cytokines (Figure <a href="/pmc/articles/PMC1564392/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2).</span></span><span>2</span></a>). The combination of IFN&#x003b1; and IFN&#x003b3; consistently yielded the greatest reduction in virus replication. Therefore, this mixture of cytokines, and IL-2 which is not known to have direct antiviral activity, were included as internal positive and negative controls, respectively, in each plate of every experiment.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC1564392/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140544225119488" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig2_HTML.jpg" src="/pmc/articles/PMC1564392/bin/12985_2006_Article_175_Fig2_HTML.jpg" /></div><div id="largeobj_idm140544225119488" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1564392/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC1564392/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p12"><strong>Establishment of internal controls: IFN&#x003b1; and IFN&#x003b3; reduce rotavirus infectivity in the assay</strong>. Cells were treated with indicated amounts of each cytokine or a combination of both prior to infection. Infections were allowed to proceed for 18 hours and chemiluminescent measurement of reduction in rotavirus infectivity was performed as described in the text and in the legend to Figure 1. Error bars are standard errors of the means.</p></div></div></div></div><div id="Sec4" class="sec"><h3 id="Sec4title">Assay validation</h3><p id="__p13" class="p p-first">Plate uniformity assessments were performed according to the recommendations of the NIH Chemical Genomics Center in order to determine whether our assay was suitable for eventual adaptation to a high-throughput format. The Z\' coefficient was established with mock infected cells representing the minimum signal value, virus infected cells representing the maximum signal value, and the IFN&#x003b1;/IFN&#x003b3; mixture as the midrange signal. Experiments consisting of three plates each run on three consecutive days were performed and an example of the data from one day is shown in Figure <a href="/pmc/articles/PMC1564392/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure3.</span></span><span>3</span></a>. No evidence of significant drift or edge effect was observed. The Z\' coefficient measures the quality of an HTS assay by comparing data variation and the signal dynamic range, and a value of &#x0003e; 0.5 establishes the assay as excellent for screening [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713411">12</a>, <a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713406">13</a>]. The Z\' values ranged from 0.69 &#x02013; 0.82 for individual plates, and the aggregate Z\' value from all plates and all days was 0.64. A signal-to-noise value of 4.96 was calculated with the aggregate data from all plates. All of the statistical criteria for intra-plate assessment were met [<a href="#CR14" rid="CR14" class=" bibr popnode">14</a>].</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC1564392/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140544259634624" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig3_HTML.jpg" src="/pmc/articles/PMC1564392/bin/12985_2006_Article_175_Fig3_HTML.jpg" /></div><div id="largeobj_idm140544259634624" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1564392/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC1564392/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p15"><strong>Assay validation</strong>. Cells were treated according the provided template [14]. Three individual experiments, each containing three plates, were conducted on three separate days. A) The left panels show a representative set of data from day two of the plate uniformity assay with the data graphed in a well-row orientation where the wells are labeled horizontally. The panels on the right contain the same data in a well-column orientation. B) Aggregate data of all nine plates over three days in a well-row orientation.</p></div></div></div><p id="__p14" class="p p-last">The assay results show some inter-plate variability. For example, although all within-day fold-shifts in signal were less than 2, all average (between)-day fold-shifts were not. We expect some degree of variability due simply to the variations in the growth status of cells from day to day. Importantly, we established sufficient intra-plate controls to account for minor variances associated with cell status. Together the validation and statistical data support the assay as a viable platform for screening compound libraries.</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">Compounds from a natural product library reduce rotavirus infectivity</h3><p id="__p16" class="p p-first">A 280 compound natural product library was screened to identify compounds that reduced rotavirus infectivity. Forty-seven (17%) compounds were selected for a second round of screening and were tested both for dose-dependency and for effects on cell viability. A representative dataset is shown in Figure <a href="/pmc/articles/PMC1564392/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure4.</span></span><span>4</span></a>. Figure <a href="/pmc/articles/PMC1564392/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure4A</span></span><span>4A</span></a> shows data obtained from the initial screen, and the data in figure <a href="/pmc/articles/PMC1564392/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">figure4B</span></span><span>4B</span></a> illustrate dose-dependent reductions in rotavirus infectivity in response to treatment of cells with each of the four representative compounds. The observed reduction in infectivity was not a result of generalized cytotoxicity because cell viability did not decrease upon treatment beyond the DMSO only controls (Figure <a href="/pmc/articles/PMC1564392/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure4B).</span></span><span>4B</span></a>). The one exception was that mangostin was toxic at 10 &#x003bc;g/ml. Dose-dependency and cell viability assays were performed in parallel with cells seeded at the same densities from the same cell suspension.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC1564392/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140544218626960" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig4_HTML.jpg" src="/pmc/articles/PMC1564392/bin/12985_2006_Article_175_Fig4_HTML.jpg" /></div><div id="largeobj_idm140544218626960" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1564392/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC1564392/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p17"><strong>Natural products identified in the MTS assay reduce rotavirus infectivity in a dose-dependent manner</strong>. Representative data are shown for four compounds: 18-&#x003b2;-glycyrrhetinic acid, abietic acid, mangostin, and all-<em>trans</em> retinoic acid. A) Data from initial screen. The <em>y</em>-axis is relative light units (n = 3). B) Secondary screen that includes a dose-response (red) and cell viability (blue) data. The left <em>y</em>-axis is relative light units and the right <em>y</em>-axis is viability (n = 3). Error bars are standard errors of the means. The highest concentration of mangostin was toxic under the conditions of this assay.</p></div></div></div><p id="__p18" class="p p-last">Forty-seven compounds from the primary screen were subjected to second round screening and 32 were eliminated from consideration for follow-up studies. Ten compounds did not reduce infectivity above the established threshold in the second round, generating a true false positive hit rate of ~20%. Twenty compounds proved cytotoxic as measured by the cell viability assay, and two compounds are known toxins with gross effects on cell metabolism (e.g. protein synthesis inhibitors). The two toxins were eliminated from further consideration because we are interested in identifying compounds that stimulate or enhance antiviral signaling pathways. The remaining 15 compounds were designated true hits (5 %) and are listed in Table <a href="/pmc/articles/PMC1564392/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1</span></span><span>1</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p19">Compounds that reduce rotavirus infectivity without cytotoxicity</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140544217718736" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Manufacturer\'s ID Number</th><th align="center" rowspan="1" colspan="1">Chemical Name</th><th align="center" rowspan="1" colspan="1">FW</th><th align="center" rowspan="1" colspan="1">Chemical Family</th><th align="center" rowspan="1" colspan="1">Known Functions (Select references)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">\n<strong>Group A</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713384" class="tag_hotlink" href="/protein/TNP00130" ref="/protein/TNP00130"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00130","term_id":"1684947752","term_text":"TNP00130"}}</span>TNP00130</a></td><td align="center" rowspan="1" colspan="1">18-&#x003b2;-Glycyrrhetinic Acid</td><td align="center" rowspan="1" colspan="1">470.68</td><td align="center" rowspan="1" colspan="1">Triterpene</td><td align="center" rowspan="1" colspan="1"><p id="__p20">-Antiviral activity against a number of DNA and RNA viruses [25]</p><p id="__p21">-Inhibits gap junction communication</p></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713391" class="tag_hotlink" href="/protein/TNP00088" ref="/protein/TNP00088"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00088","term_id":"1684947710","term_text":"TNP00088"}}</span>TNP00088</a></td><td align="center" rowspan="1" colspan="1">Abietic Acid</td><td align="center" rowspan="1" colspan="1">302.45</td><td align="center" rowspan="1" colspan="1">Diterpene</td><td align="center" rowspan="1" colspan="1"><p id="__p22">-Inhibits acute inflammation after topical or oral administration [26]</p><p id="__p23">-Reduces neutrophil infiltration [26]</p><p id="__p24">-Reduces COX-2 and TNF-&#x003b1; expression [16]</p><p id="__p25">-Activates PPAR-&#x003b3; in macrophages [16]</p></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713394" class="tag_hotlink" href="/protein/TNP00194" ref="/protein/TNP00194"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00194","term_id":"1684947819","term_text":"TNP00194"}}</span>TNP00194</a></td><td align="center" rowspan="1" colspan="1">All-<em>trans</em>-Retinoic Acid</td><td align="center" rowspan="1" colspan="1">300.44</td><td align="center" rowspan="1" colspan="1">Retinoid</td><td align="center" rowspan="1" colspan="1">-Increases expression of type I interferon receptors [27]</td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713392" class="tag_hotlink" href="/protein/TNP00140" ref="/protein/TNP00140"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00140","term_id":"1684947763","term_text":"TNP00140"}}</span>TNP00140</a></td><td align="center" rowspan="1" colspan="1">&#x003b1;-Mangostin</td><td align="center" rowspan="1" colspan="1">410.46</td><td align="center" rowspan="1" colspan="1">Xanthone</td><td align="center" rowspan="1" colspan="1"><p id="__p26">-Used in treatment of skin infections, wounds and diarrhea in Southeast Asia [15]</p><p id="__p27">-&#x003b3;-Mangostin inhibits NF-&#x003ba;B activation and COX-2 expression [15]</p><p id="__p28">-&#x003b1;-Mangostin preferentially inhibits growth of HL60 cells [28]</p><p id="__p29">-Induces caspase-9 and -3 activation in HL60 cells [28]</p></td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Group B</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713388" class="tag_hotlink" href="/protein/TNP00307" ref="/protein/TNP00307"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00307","term_id":"1684947935","term_text":"TNP00307"}}</span>TNP00307</a></td><td align="center" rowspan="1" colspan="1">Kinetin-9-Riboside</td><td align="center" rowspan="1" colspan="1">347.33</td><td align="center" rowspan="1" colspan="1">Phytohormone</td><td align="center" rowspan="1" colspan="1"><p id="__p30">-Cytokinin</p><p id="__p31">-Antiviral activity against Tobacco Mosaic Virus [29]</p><p id="__p32">-Causes a decrease in (poly rI) (poly rC) stimulated interferon response in VSV challenged mice [30]</p><p id="__p33">-Reverses the effect of endotoxin-enhanced host resistance [31]</p></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713385" class="tag_hotlink" href="/protein/TNP00064" ref="/protein/TNP00064"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00064","term_id":"1684947686","term_text":"TNP00064"}}</span>TNP00064</a></td><td align="center" rowspan="1" colspan="1">7,3\'-Dihydroxyflavone</td><td align="center" rowspan="1" colspan="1">254.24</td><td align="center" rowspan="1" colspan="1">Flavone</td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713390" class="tag_hotlink" href="/protein/TNP00050" ref="/protein/TNP00050"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00050","term_id":"1684947672","term_text":"TNP00050"}}</span>TNP00050</a></td><td align="center" rowspan="1" colspan="1">6,7-Dimethoxyflavone</td><td align="center" rowspan="1" colspan="1">282.29</td><td align="center" rowspan="1" colspan="1">Flavone</td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713387" class="tag_hotlink" href="/protein/TNP00044" ref="/protein/TNP00044"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00044","term_id":"1684947666","term_text":"TNP00044"}}</span>TNP00044</a></td><td align="center" rowspan="1" colspan="1">8-Hydroxy-7-Methoxyflavone</td><td align="center" rowspan="1" colspan="1">268.27</td><td align="center" rowspan="1" colspan="1">Flavone</td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713383" class="tag_hotlink" href="/protein/TNP00151" ref="/protein/TNP00151"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00151","term_id":"1684947776","term_text":"TNP00151"}}</span>TNP00151</a></td><td align="center" rowspan="1" colspan="1">Genistein</td><td align="center" rowspan="1" colspan="1">270.24</td><td align="center" rowspan="1" colspan="1">Isoflavone</td><td align="center" rowspan="1" colspan="1"><p id="__p34">-Tyrosine kinase inhibitor [32]</p><p id="__p35">-Down-regulates iNOS [33]</p><p id="__p36">-Inhibits NF-&#x003ba;B activation [33]</p><p id="__p37">-Inhibits COX-2 induction [33]</p><p id="__p38">-Inhibits LPS induced IL-1&#x003b2;, IL-6, and TNF-&#x003b1; production in monocytes</p></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713382" class="tag_hotlink" href="/protein/TNP00227" ref="/protein/TNP00227"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00227","term_id":"1684947855","term_text":"TNP00227"}}</span>TNP00227</a></td><td align="center" rowspan="1" colspan="1">Capsaicin</td><td align="center" rowspan="1" colspan="1">305.42</td><td align="center" rowspan="1" colspan="1">Phenylalkyl-Amine Alkaloid</td><td align="center" rowspan="1" colspan="1"><p id="__p39">-Inhibits NF-&#x003ba;B activation [34]</p><p id="__p40">-Activates transient receptor potential vanilloid-1 (TRPV-1) [35]</p></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713381" class="tag_hotlink" href="/protein/TNP00256" ref="/protein/TNP00256"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00256","term_id":"1684947884","term_text":"TNP00256"}}</span>TNP00256</a></td><td align="center" rowspan="1" colspan="1">Securinine</td><td align="center" rowspan="1" colspan="1">217.26</td><td align="center" rowspan="1" colspan="1">Pseudoalkaloid</td><td align="center" rowspan="1" colspan="1"><p id="__p41">-GABA receptor antagonist</p><p id="__p42">-Antibacterial activity against E. coli, Staph. aureus and Myc. smegmatis [36]</p><p id="__p43">-Antimalarial activity [37]</p></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713386" class="tag_hotlink" href="/protein/TNP00231" ref="/protein/TNP00231"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00231","term_id":"1684947859","term_text":"TNP00231"}}</span>TNP00231</a></td><td align="center" rowspan="1" colspan="1">Isopimaric Acid</td><td align="center" rowspan="1" colspan="1">302.46</td><td align="center" rowspan="1" colspan="1">Diterpene</td><td align="center" rowspan="1" colspan="1"><p id="__p44">-Inhibitory activity against multidrug-resistant strains of <em>Staphylococcus aureus</em> [38]</p><p id="__p45">-activates large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel &#x003b1;-subunit [39]</p></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713389" class="tag_hotlink" href="/protein/TNP00292" ref="/protein/TNP00292"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00292","term_id":"1684947920","term_text":"TNP00292"}}</span>TNP00292</a></td><td align="center" rowspan="1" colspan="1">Parthenolide</td><td align="center" rowspan="1" colspan="1">248.32</td><td align="center" rowspan="1" colspan="1">Sesquiterpene Lactone</td><td align="center" rowspan="1" colspan="1">-inhibits NF&#x003ba;B activation by preventing induction of I&#x003ba;B kinase [40]</td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713393" class="tag_hotlink" href="/protein/TNP00006" ref="/protein/TNP00006"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00006","term_id":"1684947625","term_text":"TNP00006"}}</span>TNP00006</a></td><td align="center" rowspan="1" colspan="1">Unknown</td><td align="center" rowspan="1" colspan="1">358.48</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><a id="__tag_844713395" class="tag_hotlink" href="/protein/TNP00014" ref="/protein/TNP00014"><span class="tag-json" style="display:none">{"type":"entrez-protein","attrs":{"text":"TNP00014","term_id":"1684947633","term_text":"TNP00014"}}</span>TNP00014</a></td><td align="center" rowspan="1" colspan="1">Unknown</td><td align="center" rowspan="1" colspan="1">388.50</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140544217718736" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1564392/table/Tab1/?report=objectonly">Open in a separate window</a></div></div></div><div id="Sec6" class="sec"><h3 id="Sec6title">Time course of inhibitory effects</h3><p id="__p46" class="p p-first-last">The four compounds shown as representative data in Figure <a href="/pmc/articles/PMC1564392/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure4</span></span><span>4</span></a> were analyzed further because of prior reports of their effects on components of innate immune signaling pathways [<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713396">15</a>&#x02013;<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713407">17</a>]. A time-course and dose-response of each compound were established in the immunofluorescent focus reduction assay. Cells were treated with each compound for various times ranging from 12 hours pre-infection to 2 hours post-infection (Figure <a href="/pmc/articles/PMC1564392/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure5).</span></span><span>5</span></a>). Significant levels of inhibition of virus replication were observed with each compound when added as early as 2 hours prior to infection. The level of inhibition did not change dramatically as pre-treatment times increased up to 12 hours. All compounds showed some ability to reduce infectivity when added at the time of infection, and 18-&#x003b2; glycyrrhetinic acid, all-<em>trans</em> retinoic acid and mangostin were somewhat effective when added at 1 or 2 hours post-infection. Interestingly, addition of abietic acid post-infection showed a small, but significant increase in infectivity that also was dose-dependent.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC1564392/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140544222906096" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig5_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig5_HTML.jpg" src="/pmc/articles/PMC1564392/bin/12985_2006_Article_175_Fig5_HTML.jpg" /></div><div id="largeobj_idm140544222906096" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1564392/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC1564392/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Figure 5</a></div><!--caption a7--><div class="caption"><p id="__p47"><strong>Time course of inhibition of rotavirus replication</strong>. Cells were treated with indicated compounds for various intervals ranging from 12 hr pre-infection to 2 hr post-infection. Each time point was assayed in triplicate and virus was quantified by counting FFU. Open squares are IFN control. Red, 7.5 &#x003bc;g/ml, blue, 5 &#x003bc;g/ml, and green, 2.5 &#x003bc;g/ml The <em>y</em>-axis represents percent inhibition and the <em>x</em>-axis is time of infection. Error bars are standard errors of the means (n = 3).</p></div></div></div></div><div id="Sec7" class="sec sec-last"><h3 id="Sec7title">&#x003b1;-mangostin and 18 &#x003b2;-glycyrrhetinic acid activate NF&#x003ba;B and induce IL-8 secretion</h3><p id="__p48" class="p p-first-last">The design of our assay measures inhibition of rotavirus replication but does not distinguish whether antiviral signaling pathways are activated or whether the compounds block specific steps of the virus replication cycle. To test the hypothesis that virus replication was reduced because cell signaling pathways involved in antiviral and inflammatory gene expression were induced by selected compound treatment, NF&#x003ba;B activation and IL-8 secretion was measured following each treatment. &#x003b1;-mangostin and 18 &#x003b2;-glycyrrhetinic acid induced NF&#x003ba;B activation, whereas all-<em>trans</em> retinoic acid and abietic acid did not beyond the levels of the control (Figure <a href="/pmc/articles/PMC1564392/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure6).</span></span><span>6</span></a>). The levels of IL-8 expression measured for each compound were consistent with levels of activation of NF&#x003ba;B (Figure <a href="/pmc/articles/PMC1564392/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure7</span></span><span>7</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC1564392/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140544222105152" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig6_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig6_HTML.jpg" src="/pmc/articles/PMC1564392/bin/12985_2006_Article_175_Fig6_HTML.jpg" /></div><div id="largeobj_idm140544222105152" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1564392/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC1564392/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Figure 6</a></div><!--caption a7--><div class="caption"><p id="__p49"><strong>NF&#x003ba;B activation in infected and uninfected cells in the presence of selected compounds</strong>. Infected or mock infected MA104 cells were treated with indicated compounds at a final concentration of 7.5 &#x003bc;g/ml. Nuclear extracts were prepared 6 hours post-infection and activation of NF&#x003ba;B was assessed and quantified by commercial ELISA. Squares indicate DMSO only treated cultures and triangles indicate compound treated cultures. The <em>y</em>-axis is OD<sub>450</sub> nm. The data were analyzed by two-way ANOVA (n = 3).</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig7" co-legend-rid="lgnd_Fig7"><a href="/pmc/articles/PMC1564392/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140544222101488" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig7_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_175_Fig7_HTML.jpg" src="/pmc/articles/PMC1564392/bin/12985_2006_Article_175_Fig7_HTML.jpg" /></div><div id="largeobj_idm140544222101488" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1564392/figure/Fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig7"><div><a class="figpopup" href="/pmc/articles/PMC1564392/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7">Figure 7</a></div><!--caption a7--><div class="caption"><p id="__p50"><strong>IL-8 expression cells treated with selected compounds</strong>. MA104 cells were treated with indicated compounds for 24 hours and IL-8 in the supernatants was measured with a commercial ELISA. ** = p &#x0003c; 0.01, *** = p &#x0003c; 0.001, n = 4.</p></div></div></div></div></div><div id="Sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec8title">Discussion</h2><p id="__p51" class="p p-first">We designed a MTS assay capable of identifying compounds that reduce rotavirus infectivity, toward a long-term goal of discovering compounds that activate innate immune signaling pathways to reduce the disease impact of acute viral infections. We screened a library consisting of 280 natural products purified from plant extracts, and several compounds were identified that reproducibly inhibited rotavirus replication without cytotoxicity. The assay has been validated statistically, as well as by the observation that compounds selected for further study were purchased from different sources and showed reproducible inhibition of virus replication. In addition, follow-up assays measured reductions in infectivity in response to compound treatment in the standard rotavirus IF assay and the degrees of replication inhibition and dose-dependence correlated with the values obtained in the MTS assay. We calculated a true hit rate for the natural product library of 5% and a false positive rate of ~20%. We performed numerous optimization assays to reduce variability presented by variation in growth properties of our cell line. We also have initiated a screen of a 10,000 compound synthetic chemical library, and after screening ~2500 compounds, our true hit rate is 1.8% (data not shown). These true hit percentages yield a large, but not prohibitive, number of compounds for follow-up studies both in vitro and in animal models. Together the data suggest our assay is an effective platform for screening candidate compounds for antiviral activity in adherent epithelial cells.</p><p id="__p52">In this study, we sought to identify compounds with innate immune modulating effects that resulted in cellular resistance to rotavirus infection. The format of the assay, that is, readout of reduction in infectivity, does not distinguish between compounds that act on antiviral signaling pathways and those that may target specific steps in the virus replication cycle, such as entry or replicase activity. However, two of the four compounds selected for follow-up study activated NF&#x003ba;B and induced IL-8 secretion. Moreover, <em>the majority of compounds called a hit in the screen for which data is available has been previously described to affect inflammatory or anti-inflammatory gene expression or pathogen growth in vitro</em> (Table <a href="/pmc/articles/PMC1564392/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). These observations strongly support the assertion that our assay is appropriate, but not exclusive, for discovery of immune potentiators, as we intended.</p><p id="__p53">There has been a resurgence of interest in natural products as drug candidates for a variety of reasons including increased interest in infectious disease prevention and therapy, a lower percentage of chemical properties that negatively affect permeation and absorption, and the propensity of natural products to act by affecting protein-protein interactions [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713402">18</a>]. Important for the studies described here, natural products are known to modulate immune responses and cell signaling pathways. Table <a href="/pmc/articles/PMC1564392/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1</span></span><span>1</span></a> lists compounds designated hits in this study, along with some of the reported functions. Compounds were grouped into those chosen for further study (Group A), and those known to stimulate or repress inflammatory responses or innate immune signaling pathways and two with unknown functions (Group B). Also included in Group B are compounds with reported antiviral, antibacterial, or anti-protozoan activity. We have not yet deciphered mechanisms by which these compounds inhibit rotavirus replication in vitro. However, the fact that several of the compounds, for example, abietic acid, genistein, and capsaicin, interfere with NF&#x003ba;B activation and cyclo-oxygenase 2 (COX2) expression is noteworthy (see Table <a href="/pmc/articles/PMC1564392/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1</span></span><span>1</span></a> for references). NF&#x003ba;B activation is an important regulator of COX2 expression; COX2 activity and COX-mediated prostaglandin synthesis is necessary for rotavirus infectivity in CaCo-2 intestinal cells [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713400">19</a>]. Interestingly, the addition of prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) restored infectivity reduced by the COX inhibitor [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713415">19</a>] and three of the compounds we chose for follow-up studies all have an inhibitory effect on either synthesis or release of PGE<sub>2</sub> (see Table <a href="/pmc/articles/PMC1564392/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1</span></span><span>1</span></a> references). The ability of &#x003b1;-mangostin and 18 &#x003b2;-glycyrrhetinic acid to inhibit rotavirus replication when both compounds activate NF&#x003ba;B is most likely because antiviral states are established upon treatment of the cells with each compound prior to infection. The definitive mechanisms by which the compounds identified in this natural product library screen warrant further investigation.</p><p id="__p54" class="p p-last">We intend this MTS assay to serve as a platform for discovery of candidate adjuvants that will be effective against acute viral infections at mucosal surfaces. Rotavirus is an ideal model system for these purposes for several reasons. First, rotaviruses cause gastrointestinal illness in most mammalian species and so their relevance as mucosal pathogens is clear. Second, these viruses are well characterized with respect to structure, antigenicity, and mechanisms of virus replication, and thus an excellent resource for mechanistic follow-up studies is available. Third, rotavirus is promiscuous in its tropism for cultured cell lines, and multiple cell lines of different types and species of origin, including primary cell lines [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845248319">20</a>], support productive virus replication. The ability to propagate rotavirus in a variety of cell types supports high throughput applications that study general as well as cell-type specific innate immune responses. Fourth, both small and large animal models of natural infection allow relatively rapid evaluation of the efficacy of candidate compounds in vivo. Finally, the fact that rotavirus employs a mechanism to down-regulate antiviral gene expression allows consideration of possible evasion strategies when selecting and testing candidate immune potentiators [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713417">21</a>, <a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713410">22</a>]. Current development efforts include expansion of screening studies to other lytic RNA viruses such as influenza virus, and adaptation of the assay to a fully automated format.</p></div><div id="Sec9" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec9title">Methods</h2><div id="Sec10" class="sec sec-first"><h3 id="Sec10title">Cells, virus, and rotavirus monoclonal antibodies</h3><p id="__p55" class="p p-first-last">MA104 monkey kidney epithelial cells were maintained in M199 medium (MediaTech Cell Grow) supplemented with 5% fetal bovine serum (FBS; Atlanta Biologicals). Isolation and cultivation of G serotype 6 (G6) bovine rotavirus strain NCDV has been described [<a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713414">23</a>]. Monoclonal antibody (MAb) E4 reacts with major structural protein VP6 of most group A rotavirus strains [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713399">24</a>]. MAb A6M recognizes VP6 and was generated by immunizing mice with G6 bovine rotavirus strain B641 and screening hybridoma supernatants for antibodies that react with rotavirus specific proteins.</p></div><div id="Sec11" class="sec"><h3 id="Sec11title">Reagents and chemicals</h3><p id="__p56" class="p p-first">A library containing 0.5 mg each of 280 natural products purified from plant extracts was purchased from TimTec (TimTec Corporation). Compounds were reconstituted in 500 &#x003bc;l of dimethyl sulfoxide (DMSO) and the library was stored at -80&#x000b0;C. Individual compounds &#x003b1;-mangostin (TimTec or Indofine), 18-&#x003b2;-glycyrrhetinic acid (18-BGA; Fluka), abietic acid (AA; Sigma), and all-<em>trans</em>-retinoic acid (ATRA; Sigma) were reconstituted in DMSO to final stock concentrations of 25 mg/ml.</p><p id="__p57">Recombinant human interferon-&#x003b1; (IFN-&#x003b1;; BioSource International, Inc) was diluted to a concentration of 1 &#x000d7; 10<sup>5</sup> U/ml in phosphate buffered saline (PBS) containing 0.1% bovine serum albumin (BSA). Recombinant human interferon-&#x003b3; (IFN-&#x003b3;) and recombinant human interleukin-2 (IL-2; Peprotech Inc) were diluted to 2 &#x000d7; 10<sup>6</sup> U/ml and 10 &#x003bc;g/ml, respectively, in PBS.</p><p id="__p58" class="p p-last">Horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (H+L), HRP-conjugated goat anti-mouse IgG (H+L) F(ab\')<sub>2</sub> fragments, and FITC-conjugated goat anti-mouse IgG were purchased from Jackson ImmunoResearch Laboratories.</p></div><div id="Sec12" class="sec"><h3 id="Sec12title">Screening assay</h3><div id="Sec13" class="sec sec-first"><p></p><h4 id="Sec13title" class="inline">Compound treatments and virus infections </h4><p id="__p59" class="p p-first">Working stock solutions of each compound from the library were prepared to twice the desired final concentrations of 20 &#x003bc;g/ml, 10 &#x003bc;g/ml, and 2 &#x003bc;g/ml in serum-free M199. Working stock solutions of assay controls consisted of 2%, 1% DMSO, and 0.2% DMSO, a mixture of 200 U/ml each of IFN-&#x003b1; and IFN-&#x003b3;, and 2 ng/ml of IL-2.</p><p id="__p60" class="p p-last">MA104 cells were cultured to confluence in 96-well black-walled plates (Costar). The culture media was decanted and replaced with 50 &#x003bc;l of M199. 50 &#x003bc;l of 2X control and experimental stock solutions were added to respective wells, in triplicate, and plates were incubated for 4 hours at 37&#x000b0;C. Following the 4 hour incubation, the contents of each plate were removed and 8.9 &#x000d7; 10<sup>5</sup> ffu/well of trypsin-activated NCDV in 0% M199 was added to appropriate wells. Mock infected wells received 50 &#x003bc;l of 0% M199. 50 &#x003bc;l of fresh 2X control and experimental compounds were added and at 18 hours post-infection, the cells were fixed for 10 minutes with 80% acetone.</p></div><div id="Sec14" class="sec sec-last"><p></p><h4 id="Sec14title" class="inline">Cell-based ELISA </h4><p id="__p61" class="p p-first-last">The wells were blocked for one hour at room temperature with 100 &#x003bc;l of PBS containing 3% bovine serum albumin (w/v) and 0.05% Tween-20. The plates were washed one time with 400 &#x003bc;l of wash buffer consisting of PBS and 0.05% Tween 20. 50 &#x003bc;l of 20 &#x003bc;g/ml A6M or E4 (1:25 hybridoma supernatant) in PBS containing 0.05% Tween 20 and 0.5% dry milk was added to the wells and incubated for one hour at room temperature. The plates were washed four times with wash buffer, then 50 &#x003bc;l of a 1:500 dilution of HRP-conjugated F(ab\')<sub>2</sub> in 0.5% Blotto was added and the plates were incubated for one hour at room temperature. Following a final wash, 100 &#x003bc;l of BM Chemiluminescence ELISA Substrate (Roche Diagnostics) was added and reactions were allowed to proceed for 4 minutes to reach a steady state of enzymatic activity. Signals were measured on a ThermoElectron Fluroskan (ThermoElectron Cooperation) with an integration time of 1,000 ms.</p></div></div><div id="Sec15" class="sec"><h3 id="Sec15title">Cell viability assay</h3><p id="__p62" class="p p-first-last">Cell viability assays for compound toxicity were set up similar to compound screening except cells were not infected over the course of the experiments. Cell viability was measured with the CellTiter-Glo Luminescent Cell Viability Assay (Promega) according to instructions provided by the manufacturer.</p></div><div id="Sec16" class="sec"><h3 id="Sec16title">Statistics and criteria for "hit" designation</h3><p id="__p63" class="p p-first-last">Compounds that showed a greater than 60% decrease in signal at 5 &#x003bc;g/ml when compared to the 0.5% DMSO control, and p &#x0003c; 0.05 as determined by a one-tailed student\'s <em>t</em> test, were selected for secondary screening. Additionally, compounds that showed a greater than 90% decrease in signal when compared to the 1% DMSO control and p &#x0003c; 0.05 also were selected for further screening. Compounds that showed a greater than 10% decrease in signal and a p &#x0003c; 0.05 in the cell viability assay were determined to be toxic.</p></div><div id="Sec17" class="sec"><h3 id="Sec17title">Plate uniformity assessment</h3><p id="__p64" class="p p-first">The recommendations of the National Institutes of Health Chemical Genomics Center\'s <em>Assay Guidance Manual Version 4.1</em> for plate uniformity assessments were followed. Three separate experiments consisting of three plates each were performed on three different days. Confluent MA104 cells were pretreated for 4 hours with 100 &#x003bc;l of either media or a mixture of 100 U/ml each of IFN-&#x003b1; and IFN-&#x003b3;. All media was serum free and contained 1% DMSO.</p><p id="__p65" class="p p-last">The pre-treatment media was decanted and the cells were infected with 50 &#x003bc;l of 8.9 &#x000d7; 10<sup>5</sup> pfu/ml of trypsin-activated NCDV. Mock infected wells were treated with 50 &#x003bc;l of serum free media. 50 &#x003bc;l of fresh 2X treatment media containing 2% DMSO was added to the respective wells and the plates were incubated for 18 hours. The plates were fixed, labeled and quantified according to the assay procedure described above. All calculations were performed using the Assay Guidance Manual\'s spreadsheet [<a href="#CR14" rid="CR14" class=" bibr popnode">14</a>].</p></div><div id="Sec18" class="sec"><h3 id="Sec18title">Immunofluorescent focus assay</h3><p id="__p66" class="p p-first-last">Immunofluorescent assays (IF) for rotavirus infectivity were performed as previously described [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844713408">24</a>]. Cells were cultured in 96-well plates and were mock infected or infected with NCDV at approximately 150 ffu/well. Pre- or post-treatment with compounds was performed for the indicated times as described above. 18 hours post-infection, the cells were fixed for 10 minutes with 80% acetone. Incubations with primary and secondary antibody were as described above, except the secondary antibody was FITC-conjugated goat anti-mouse IgG. Fluorescent foci were counted by microscopy (Nikon Eclipse TE300).</p></div><div id="Sec19" class="sec sec-last"><h3 id="Sec19title">NF&#x003ba;B and IL-8 assays</h3><p id="__p67" class="p p-first">MA104 cells in 100 &#x000d7; 20 mm culture dishes were treated with 7.5 &#x003bc;g/ml of selected compounds in serum-free M199 containing 0.03% DMSO. The effects of the presence of virus on NF&#x003ba;B activation and IL-8 secretion in the assays was tested by infecting cells with trypsin-activated NCDV at an moi of 10 pfu/cell at the time of compound treatment. In all cases, incubation periods were 6 hours.</p><p id="__p68">NF-&#x003ba;B activation was quantified with TransAM NF-&#x003ba;B p50 Transcription Factor Assay Kit (Active Motif). Nuclear extracts were prepared with CelLytic NuCLEAR Extraction Kit (Sigma) following the manufacturer\'s protocol. Nuclear protein concentration was determined with the D<sub>c</sub> Protein Assay (Bio-Rad Laboratories), and 20 &#x003bc;g of nuclear protein was used in the assay. Statistical analysis of the data was performed by two-factor ANOVA.</p><p id="__p69" class="p p-last">IL-8 secretion was measured with the Quantikine Human IL-8 system (R &#x00026; D Systems) following the manufacturer\'s protocol. Compound treatments and infections were performed as described above, except that the incubation periods were extended to 24 hours. The data were analyzed by student\'s <em>t</em> test with a threshold of significance set to <em>p</em> &#x0003c; 0.001.</p></div></div><div id="idm140544219994896" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140544219994896title">Acknowledgements</h2><div class="sec"><p id="__p84">This work was supported by DoD contract W9113M-04-1-0010, USDA NRI/CGP 02657 to MEH, the Montana Agriculture Experiment Station, and PHS grant P20 RR020185. ADB gratefully acknowledges financial support from the Arnold and Mabel Beckman Foundation administered through the MSU Beckman Scholars Program.</p></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec20" class="sec sec-first"><h3 id="Sec20title">Authors&#x02019; original submitted files for images</h3><p id="__p70" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC1564392/bin/12985_2006_175_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(95K, pdf)</sup></span><span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC1564392/bin/12985_2006_175_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(106K, pdf)</sup></span><span class="sup-box" id="MOESM3"><a href="/pmc/articles/PMC1564392/bin/12985_2006_175_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 3</a><sup>(48K, pdf)</sup></span><span class="sup-box" id="MOESM4"><a href="/pmc/articles/PMC1564392/bin/12985_2006_175_MOESM4_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 4</a><sup>(57K, pdf)</sup></span><span class="sup-box" id="MOESM5"><a href="/pmc/articles/PMC1564392/bin/12985_2006_175_MOESM5_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 5</a><sup>(116K, pdf)</sup></span><span class="sup-box" id="MOESM6"><a href="/pmc/articles/PMC1564392/bin/12985_2006_175_MOESM6_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 6</a><sup>(109K, pdf)</sup></span><span class="sup-box" id="MOESM7"><a href="/pmc/articles/PMC1564392/bin/12985_2006_175_MOESM7_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 7</a><sup>(109K, pdf)</sup></span><span class="sup-box" id="MOESM8"><a href="/pmc/articles/PMC1564392/bin/12985_2006_175_MOESM8_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 8</a><sup>(104K, pdf)</sup></span><span class="sup-box" id="MOESM9"><a href="/pmc/articles/PMC1564392/bin/12985_2006_175_MOESM9_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 9</a><sup>(104K, pdf)</sup></span></p></div></div><div id="idm140544219998368" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140544219998368title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140544219998240"><p id="__p80" class="p p-first"><strong>Competing interests</strong></p><p id="__p81" class="p p-last">The author(s) declare that they have no competing interests.</p></p><p class="fn sec" id="idm140544219996832"><p id="__p82" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p83" class="p p-last">MES established the assay, performed most of the experiments and assisted in preparation of the manuscript. ADB performed a significant number of screening assays and data analysis, and participated in manuscript preparation. JWG purified and characterized virus stocks, assisted in assay development and in manuscript preparation. MAJ contributed to study design, assay development, data analysis and manuscript preparation. MEH conceived of the study, participated in design and is responsible for study oversight.</p></p></div></div><div id="idm140544216914288aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140544216914288aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Mark E Shaneyfelt, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.agaznog@fyenahsm" class="oemail">ude.agaznog@fyenahsm</a></span>.</p><p><span class="fm-affl">Anna D Burke, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.anatnom@ekrubanna" class="oemail">ude.anatnom@ekrubanna</a></span>.</p><p><span class="fm-affl">Joel W Graff, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.anatnom@ffargj" class="oemail">ude.anatnom@ffargj</a></span>.</p><p><span class="fm-affl">Mark A Jutila, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.anatnom@jmsvu" class="oemail">ude.anatnom@jmsvu</a></span>.</p><p><span class="fm-affl">Michele E Hardy, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.anatnom@ydrahm" class="oemail">ude.anatnom@ydrahm</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Hackett CJ. Innate immune activation as a broad-spectrum biodefense strategy: prospects and research challenges. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2003;<span class="ref-vol">112</span>:686\xe2\x80\x93694. doi: 10.1016/S0091-6749(03)02025-6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7125525/">PMC free article</a>]</span> [<a href="/pubmed/14564345" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0091-6749(03)02025-6" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol&amp;title=Innate+immune+activation+as+a+broad-spectrum+biodefense+strategy:+prospects+and+research+challenges&amp;author=CJ+Hackett&amp;volume=112&amp;publication_year=2003&amp;pages=686-694&amp;pmid=14564345&amp;doi=10.1016/S0091-6749(03)02025-6&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Pashine A, Valiante NM, Ulmer JB. Targeting the innate immune response with improved vaccine adjuvants. <span><span class="ref-journal">Nat Med. </span>2005;<span class="ref-vol">11</span>:S63\xe2\x80\x93S68. doi: 10.1038/nm1210.</span> [<a href="/pubmed/15812492" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnm1210" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Targeting+the+innate+immune+response+with+improved+vaccine+adjuvants&amp;author=A+Pashine&amp;author=NM+Valiante&amp;author=JB+Ulmer&amp;volume=11&amp;publication_year=2005&amp;pages=S63-S68&amp;pmid=15812492&amp;doi=10.1038/nm1210&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Amlie-Lefond C, Paz DA, Connelly MP, Huffnagle GB, Whelan NT, Whelan HT. Innate immunity for biodefense: a strategy whose time has come. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2005;<span class="ref-vol">116</span>:1334\xe2\x80\x931342. doi: 10.1016/j.jaci.2005.08.048.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7127501/">PMC free article</a>]</span> [<a href="/pubmed/16337468" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jaci.2005.08.048" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol&amp;title=Innate+immunity+for+biodefense:+a+strategy+whose+time+has+come&amp;author=C+Amlie-Lefond&amp;author=DA+Paz&amp;author=MP+Connelly&amp;author=GB+Huffnagle&amp;author=NT+Whelan&amp;volume=116&amp;publication_year=2005&amp;pages=1334-1342&amp;pmid=16337468&amp;doi=10.1016/j.jaci.2005.08.048&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Johnston PA, Johnston PA. Cellular platforms for HTS: three case studies. <span><span class="ref-journal">Drug Discov Today. </span>2002;<span class="ref-vol">7</span>:353\xe2\x80\x93363. doi: 10.1016/S1359-6446(01)02140-7.</span> [<a href="/pubmed/11893544" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS1359-6446(01)02140-7" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov+Today&amp;title=Cellular+platforms+for+HTS:+three+case+studies&amp;author=PA+Johnston&amp;author=PA+Johnston&amp;volume=7&amp;publication_year=2002&amp;pages=353-363&amp;pmid=11893544&amp;doi=10.1016/S1359-6446(01)02140-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">O\'Boyle DR, Nower PT, Lemm JA, Valera L, Sun JH, Rigat K, Colonno R, Gao M. Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay. <span><span class="ref-journal">Antimicrob Agents Chemother. </span>2005;<span class="ref-vol">49</span>:1346\xe2\x80\x931353. doi: 10.1128/AAC.49.4.1346-1353.2005.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1068622/">PMC free article</a>]</span> [<a href="/pubmed/15793110" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FAAC.49.4.1346-1353.2005" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob+Agents+Chemother&amp;title=Development+of+a+cell-based+high-throughput+specificity+screen+using+a+hepatitis+C+virus-bovine+viral+diarrhea+virus+dual+replicon+assay&amp;author=DR+O\'Boyle&amp;author=PT+Nower&amp;author=JA+Lemm&amp;author=L+Valera&amp;author=JH+Sun&amp;volume=49&amp;publication_year=2005&amp;pages=1346-1353&amp;pmid=15793110&amp;doi=10.1128/AAC.49.4.1346-1353.2005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Blair WS, Isaacson J, Li X, Cao J, Peng Q, Kong GF, Patick AK. A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors. <span><span class="ref-journal">Antiviral Res. </span>2005;<span class="ref-vol">65</span>:107\xe2\x80\x93116. doi: 10.1016/j.antiviral.2004.11.001.</span> [<a href="/pubmed/15708637" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.antiviral.2004.11.001" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antiviral+Res&amp;title=A+novel+HIV-1+antiviral+high+throughput+screening+approach+for+the+discovery+of+HIV-1+inhibitors&amp;author=WS+Blair&amp;author=J+Isaacson&amp;author=X+Li&amp;author=J+Cao&amp;author=Q+Peng&amp;volume=65&amp;publication_year=2005&amp;pages=107-116&amp;pmid=15708637&amp;doi=10.1016/j.antiviral.2004.11.001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Adelson ME, Pacchia AL, Kaul M, Rando RF, Ron Y, Peltz SW, Dougherty JP. Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1. <span><span class="ref-journal">Antimicrob Agents Chemother. </span>2003;<span class="ref-vol">47</span>:501\xe2\x80\x93508. doi: 10.1128/AAC.47.2.501-508.2003.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC151745/">PMC free article</a>]</span> [<a href="/pubmed/12543650" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FAAC.47.2.501-508.2003" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob+Agents+Chemother&amp;title=Toward+the+development+of+a+virus-cell-based+assay+for+the+discovery+of+novel+compounds+against+human+immunodeficiency+virus+type+1&amp;author=ME+Adelson&amp;author=AL+Pacchia&amp;author=M+Kaul&amp;author=RF+Rando&amp;author=Y+Ron&amp;volume=47&amp;publication_year=2003&amp;pages=501-508&amp;pmid=12543650&amp;doi=10.1128/AAC.47.2.501-508.2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Ivens T, Eynde CV, Acker KV, Nijs E, Dams G, Bettens E, Ohagen A, Pauwels R, Hertogs K. Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirus. <span><span class="ref-journal">J Virol Methods. </span>2005;<span class="ref-vol">129</span>:56\xe2\x80\x9363. doi: 10.1016/j.jviromet.2005.05.010.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112772/">PMC free article</a>]</span> [<a href="/pubmed/15961169" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jviromet.2005.05.010" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol+Methods&amp;title=Development+of+a+homogeneous+screening+assay+for+automated+detection+of+antiviral+agents+active+against+severe+acute+respiratory+syndrome-associated+coronavirus&amp;author=T+Ivens&amp;author=CV+Eynde&amp;author=KV+Acker&amp;author=E+Nijs&amp;author=G+Dams&amp;volume=129&amp;publication_year=2005&amp;pages=56-63&amp;pmid=15961169&amp;doi=10.1016/j.jviromet.2005.05.010&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. <span><span class="ref-journal">Emerg Infect Dis. </span>2003;<span class="ref-vol">9</span>:565\xe2\x80\x93572. doi: 10.3201/eid0905.020562.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2972763/">PMC free article</a>]</span> [<a href="/pubmed/12737740" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.3201%2Feid0905.020562" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Emerg+Infect+Dis&amp;title=Global+illness+and+deaths+caused+by+rotavirus+disease+in+children&amp;author=UD+Parashar&amp;author=EG+Hummelman&amp;author=JS+Bresee&amp;author=MA+Miller&amp;author=RI+Glass&amp;volume=9&amp;publication_year=2003&amp;pages=565-572&amp;pmid=12737740&amp;doi=10.3201/eid0905.020562&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Ward RL. Rotavirus vaccines: is the second time the charm? <span><span class="ref-journal">Curr Opin Investig Drugs. </span>2005;<span class="ref-vol">6</span>:798\xe2\x80\x93803.</span> [<a href="/pubmed/16121686" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Investig+Drugs&amp;title=Rotavirus+vaccines:+is+the+second+time+the+charm?&amp;author=RL+Ward&amp;volume=6&amp;publication_year=2005&amp;pages=798-803&amp;pmid=16121686&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Knowlton DR, Spector DM, Ward RL. Development of an improved method for measuring neutralizing antibody to rotavirus. <span><span class="ref-journal">J Virol Methods. </span>1991;<span class="ref-vol">33</span>:127\xe2\x80\x93134. doi: 10.1016/0166-0934(91)90013-P.</span> [<a href="/pubmed/1658027" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0166-0934(91)90013-P" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol+Methods&amp;title=Development+of+an+improved+method+for+measuring+neutralizing+antibody+to+rotavirus&amp;author=DR+Knowlton&amp;author=DM+Spector&amp;author=RL+Ward&amp;volume=33&amp;publication_year=1991&amp;pages=127-134&amp;pmid=1658027&amp;doi=10.1016/0166-0934(91)90013-P&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Iversen PW, Eastwood BJ, Sittampalam GS, Cox KL. A comparison of assay performance measures in screening assays: signal window, Z\' factor, and assay variability ratio. <span><span class="ref-journal">J Biomol Screen. </span>2006;<span class="ref-vol">11</span>:247\xe2\x80\x93252. doi: 10.1177/1087057105285610.</span> [<a href="/pubmed/16490779" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1177%2F1087057105285610" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biomol+Screen&amp;title=A+comparison+of+assay+performance+measures+in+screening+assays:+signal+window,+Z\'+factor,+and+assay+variability+ratio&amp;author=PW+Iversen&amp;author=BJ+Eastwood&amp;author=GS+Sittampalam&amp;author=KL+Cox&amp;volume=11&amp;publication_year=2006&amp;pages=247-252&amp;pmid=16490779&amp;doi=10.1177/1087057105285610&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Zhang JH, Chung TD, Oldenburg KR. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. <span><span class="ref-journal">J Biomol Screen. </span>1999;<span class="ref-vol">4</span>:67\xe2\x80\x9373. doi: 10.1177/108705719900400206.</span> [<a href="/pubmed/10838414" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1177%2F108705719900400206" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biomol+Screen&amp;title=A+Simple+Statistical+Parameter+for+Use+in+Evaluation+and+Validation+of+High+Throughput+Screening+Assays&amp;author=JH+Zhang&amp;author=TD+Chung&amp;author=KR+Oldenburg&amp;volume=4&amp;publication_year=1999&amp;pages=67-73&amp;pmid=10838414&amp;doi=10.1177/108705719900400206&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="mixed-citation">[<a href="http://www.ncgc.nih.gov/docs/96wellPlateUniformity.xls" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncgc.nih.gov/docs/96wellPlateUniformity.xls</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Nakatani K, Yamakuni T, Kondo N, Arakawa T, Oosawa K, Shimura S, Inoue H, Ohizumi Y. gamma-Mangostin inhibits inhibitor-kappaB kinase activity and decreases lipopolysaccharide-induced cyclooxygenase-2 gene expression in C6 rat glioma cells. <span><span class="ref-journal">Mol Pharmacol. </span>2004;<span class="ref-vol">66</span>:667\xe2\x80\x93674. doi: 10.1124/mol.104.002626.</span> [<a href="/pubmed/15322259" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1124%2Fmol.104.002626" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;title=gamma-Mangostin+inhibits+inhibitor-kappaB+kinase+activity+and+decreases+lipopolysaccharide-induced+cyclooxygenase-2+gene+expression+in+C6+rat+glioma+cells&amp;author=K+Nakatani&amp;author=T+Yamakuni&amp;author=N+Kondo&amp;author=T+Arakawa&amp;author=K+Oosawa&amp;volume=66&amp;publication_year=2004&amp;pages=667-674&amp;pmid=15322259&amp;doi=10.1124/mol.104.002626&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Takahashi N, Kawada T, Goto T, Kim CS, Taimatsu A, Egawa K, Yamamoto T, Jisaka M, Nishimura K, Yokota K, Yu R, Fushiki T. Abietic acid activates peroxisome proliferator-activated receptor-gamma (PPARgamma) in RAW264.7 macrophages and 3T3-L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism. <span><span class="ref-journal">FEBS Lett. </span>2003;<span class="ref-vol">550</span>:190\xe2\x80\x93194. doi: 10.1016/S0014-5793(03)00859-7.</span> [<a href="/pubmed/12935909" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0014-5793(03)00859-7" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;title=Abietic+acid+activates+peroxisome+proliferator-activated+receptor-gamma+(PPARgamma)+in+RAW264.7+macrophages+and+3T3-L1+adipocytes+to+regulate+gene+expression+involved+in+inflammation+and+lipid+metabolism&amp;author=N+Takahashi&amp;author=T+Kawada&amp;author=T+Goto&amp;author=CS+Kim&amp;author=A+Taimatsu&amp;volume=550&amp;publication_year=2003&amp;pages=190-194&amp;pmid=12935909&amp;doi=10.1016/S0014-5793(03)00859-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Kolla V, Lindner DJ, Xiao W, Borden EC, Kalvakolanu DV. Modulation of interferon (IFN)-inducible gene expression by retinoic acid. Up-regulation of STAT1 protein in IFN-unresponsive cells. <span><span class="ref-journal">J Biol Chem. </span>1996;<span class="ref-vol">271</span>:10508\xe2\x80\x9310514. doi: 10.1074/jbc.271.18.10508.</span> [<a href="/pubmed/8631848" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1074%2Fjbc.271.18.10508" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Modulation+of+interferon+(IFN)-inducible+gene+expression+by+retinoic+acid.+Up-regulation+of+STAT1+protein+in+IFN-unresponsive+cells&amp;author=V+Kolla&amp;author=DJ+Lindner&amp;author=W+Xiao&amp;author=EC+Borden&amp;author=DV+Kalvakolanu&amp;volume=271&amp;publication_year=1996&amp;pages=10508-10514&amp;pmid=8631848&amp;doi=10.1074/jbc.271.18.10508&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Koehn FE, Carter GT. The evolving role of natural products in drug discovery. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2005;<span class="ref-vol">4</span>:206\xe2\x80\x93220. doi: 10.1038/nrd1657.</span> [<a href="/pubmed/15729362" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnrd1657" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=The+evolving+role+of+natural+products+in+drug+discovery&amp;author=FE+Koehn&amp;author=GT+Carter&amp;volume=4&amp;publication_year=2005&amp;pages=206-220&amp;pmid=15729362&amp;doi=10.1038/nrd1657&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Rossen JW, Bouma J, Raatgeep RH, Buller HA, Einerhand AW. Inhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step. <span><span class="ref-journal">J Virol. </span>2004;<span class="ref-vol">78</span>:9721\xe2\x80\x939730. doi: 10.1128/JVI.78.18.9721-9730.2004.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC514972/">PMC free article</a>]</span> [<a href="/pubmed/15331705" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.78.18.9721-9730.2004" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Inhibition+of+cyclooxygenase+activity+reduces+rotavirus+infection+at+a+postbinding+step&amp;author=JW+Rossen&amp;author=J+Bouma&amp;author=RH+Raatgeep&amp;author=HA+Buller&amp;author=AW+Einerhand&amp;volume=78&amp;publication_year=2004&amp;pages=9721-9730&amp;pmid=15331705&amp;doi=10.1128/JVI.78.18.9721-9730.2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Buckner D, Wilson S, Kurk S, Hardy M, Miessner N, Jutila MA.  <span class="ref-journal">J Biomol Screen.</span> 2006. Use of Early Passage Fetal Intestinal Epithelial Cells in Semi-high-throughput Screening Assays: An Approach to Identify New Innate Immune System Adjuvants. [<a href="/pubmed/16923848" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=J+Biomol+Screen&amp;author=D+Buckner&amp;author=S+Wilson&amp;author=S+Kurk&amp;author=M+Hardy&amp;author=N+Miessner&amp;publication_year=2006&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Graff JW, Mitzel DN, Weisend CM, Flenniken ML, Hardy ME. Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1. <span><span class="ref-journal">J Virol. </span>2002;<span class="ref-vol">76</span>:9545\xe2\x80\x939550. doi: 10.1128/JVI.76.18.9545-9550.2002.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC136439/">PMC free article</a>]</span> [<a href="/pubmed/12186937" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.76.18.9545-9550.2002" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Interferon+regulatory+factor+3+is+a+cellular+partner+of+rotavirus+NSP1&amp;author=JW+Graff&amp;author=DN+Mitzel&amp;author=CM+Weisend&amp;author=ML+Flenniken&amp;author=ME+Hardy&amp;volume=76&amp;publication_year=2002&amp;pages=9545-9550&amp;pmid=12186937&amp;doi=10.1128/JVI.76.18.9545-9550.2002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Barro M, Patton JT. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2005;<span class="ref-vol">102</span>:4114\xe2\x80\x934119. doi: 10.1073/pnas.0408376102.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC554789/">PMC free article</a>]</span> [<a href="/pubmed/15741273" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.0408376102" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Rotavirus+nonstructural+protein+1+subverts+innate+immune+response+by+inducing+degradation+of+IFN+regulatory+factor+3&amp;author=M+Barro&amp;author=JT+Patton&amp;volume=102&amp;publication_year=2005&amp;pages=4114-4119&amp;pmid=15741273&amp;doi=10.1073/pnas.0408376102&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Woode GN, Kelso NE, Simpson TF, Gaul SK, Evans LE, Babiuk L. Antigenic relationships among some bovine rotaviruses: serum neutralization and cross-protection in gnotobiotic calves. <span><span class="ref-journal">J Clin Microbiol. </span>1983;<span class="ref-vol">18</span>:358\xe2\x80\x93364.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC270805/">PMC free article</a>]</span> [<a href="/pubmed/6311873" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Antigenic+relationships+among+some+bovine+rotaviruses:+serum+neutralization+and+cross-protection+in+gnotobiotic+calves&amp;author=GN+Woode&amp;author=NE+Kelso&amp;author=TF+Simpson&amp;author=SK+Gaul&amp;author=LE+Evans&amp;volume=18&amp;publication_year=1983&amp;pages=358-364&amp;pmid=6311873&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Zheng SL, Woode GN, Melendy DR, Ramig RF. Comparative studies of the antigenic polypeptide species VP4, VP6, and VP7 of three strains of bovine rotavirus. <span><span class="ref-journal">J Clin Microbiol. </span>1989;<span class="ref-vol">27</span>:1939\xe2\x80\x931945.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC267713/">PMC free article</a>]</span> [<a href="/pubmed/2476464" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Comparative+studies+of+the+antigenic+polypeptide+species+VP4,+VP6,+and+VP7+of+three+strains+of+bovine+rotavirus&amp;author=SL+Zheng&amp;author=GN+Woode&amp;author=DR+Melendy&amp;author=RF+Ramig&amp;volume=27&amp;publication_year=1989&amp;pages=1939-1945&amp;pmid=2476464&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Pompei R, Flore O, Marccialis MA, Pani A, Loddo B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. <span><span class="ref-journal">Nature. </span>1979;<span class="ref-vol">281</span>:689\xe2\x80\x93690. doi: 10.1038/281689a0.</span> [<a href="/pubmed/233133" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F281689a0" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Glycyrrhizic+acid+inhibits+virus+growth+and+inactivates+virus+particles&amp;author=R+Pompei&amp;author=O+Flore&amp;author=MA+Marccialis&amp;author=A+Pani&amp;author=B+Loddo&amp;volume=281&amp;publication_year=1979&amp;pages=689-690&amp;pmid=233133&amp;doi=10.1038/281689a0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Fernandez MA, Tornos MP, Garcia MD, de las HB, Villar AM, Saenz MT. Anti-inflammatory activity of abietic acid, a diterpene isolated from Pimenta racemosa var. grissea. <span><span class="ref-journal">J Pharm Pharmacol. </span>2001;<span class="ref-vol">53</span>:867\xe2\x80\x93872. doi: 10.1211/0022357011776027.</span> [<a href="/pubmed/11428663" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1211%2F0022357011776027" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Pharmacol&amp;title=Anti-inflammatory+activity+of+abietic+acid,+a+diterpene+isolated+from+Pimenta+racemosa+var.+grissea&amp;author=MA+Fernandez&amp;author=MP+Tornos&amp;author=MD+Garcia&amp;author=HB+de+las&amp;author=AM+Villar&amp;volume=53&amp;publication_year=2001&amp;pages=867-872&amp;pmid=11428663&amp;doi=10.1211/0022357011776027&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Hamamoto S, Fukuda R, Ishimura N, Rumi MA, Kazumori H, Uchida Y, Kadowaki Y, Ishihara S, Kinoshita Y. 9-cis retinoic acid enhances the antiviral effect of interferon on hepatitis C virus replication through increased expression of type I interferon receptor. <span><span class="ref-journal">J Lab Clin Med. </span>2003;<span class="ref-vol">141</span>:58\xe2\x80\x9366. doi: 10.1067/mlc.2003.8.</span> [<a href="/pubmed/12518169" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1067%2Fmlc.2003.8" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Lab+Clin+Med&amp;title=9-cis+retinoic+acid+enhances+the+antiviral+effect+of+interferon+on+hepatitis+C+virus+replication+through+increased+expression+of+type+I+interferon+receptor&amp;author=S+Hamamoto&amp;author=R+Fukuda&amp;author=N+Ishimura&amp;author=MA+Rumi&amp;author=H+Kazumori&amp;volume=141&amp;publication_year=2003&amp;pages=58-66&amp;pmid=12518169&amp;doi=10.1067/mlc.2003.8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Matsumoto K, Akao Y, Yi H, Ohguchi K, Ito T, Tanaka T, Kobayashi E, Iinuma M, Nozawa Y. Preferential target is mitochondria in alpha-mangostin-induced apoptosis in human leukemia HL60 cells. <span><span class="ref-journal">Bioorg Med Chem. </span>2004;<span class="ref-vol">12</span>:5799\xe2\x80\x935806. doi: 10.1016/j.bmc.2004.08.034.</span> [<a href="/pubmed/15498656" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.bmc.2004.08.034" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg+Med+Chem&amp;title=Preferential+target+is+mitochondria+in+alpha-mangostin-induced+apoptosis+in+human+leukemia+HL60+cells&amp;author=K+Matsumoto&amp;author=Y+Akao&amp;author=H+Yi&amp;author=K+Ohguchi&amp;author=T+Ito&amp;volume=12&amp;publication_year=2004&amp;pages=5799-5806&amp;pmid=15498656&amp;doi=10.1016/j.bmc.2004.08.034&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Milo GE, Jr, Srivastava BI. Effect of cytokinins on tobacco mosaic virus production in tobacco pith tissue cultures. <span><span class="ref-journal">Virology. </span>1969;<span class="ref-vol">39</span>:621\xe2\x80\x93623. doi: 10.1016/0042-6822(69)90118-4.</span> [<a href="/pubmed/5358090" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0042-6822(69)90118-4" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Effect+of+cytokinins+on+tobacco+mosaic+virus+production+in+tobacco+pith+tissue+cultures&amp;author=GE+Milo&amp;author=BI+Srivastava&amp;volume=39&amp;publication_year=1969&amp;pages=621-623&amp;pmid=5358090&amp;doi=10.1016/0042-6822(69)90118-4&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">De Clercq E, Nuwer MR, Merigan TC. The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice. <span><span class="ref-journal">J Clin Invest. </span>1970;<span class="ref-vol">49</span>:1565\xe2\x80\x931577. doi: 10.1172/JCI106374.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC322636/">PMC free article</a>]</span> [<a href="/pubmed/4317283" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1172%2FJCI106374" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=The+role+of+interferon+in+the+protective+effect+of+a+synthetic+double-stranded+polyribonucleotide+against+intranasal+vesicular+stomatitis+virus+challenge+in+mice&amp;author=E+De+Clercq&amp;author=MR+Nuwer&amp;author=TC+Merigan&amp;volume=49&amp;publication_year=1970&amp;pages=1565-1577&amp;pmid=4317283&amp;doi=10.1172/JCI106374&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Kessel RW, Braun W. Endotoxin-enhanced host resistance: reversal by kinetin riboside. <span><span class="ref-journal">Nature. </span>1966;<span class="ref-vol">211</span>:1001\xe2\x80\x931002. doi: 10.1038/2111001a0.</span> [<a href="/pubmed/4961272" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F2111001a0" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Endotoxin-enhanced+host+resistance:+reversal+by+kinetin+riboside&amp;author=RW+Kessel&amp;author=W+Braun&amp;volume=211&amp;publication_year=1966&amp;pages=1001-1002&amp;pmid=4961272&amp;doi=10.1038/2111001a0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. <span><span class="ref-journal">J Biol Chem. </span>1987;<span class="ref-vol">262</span>:5592\xe2\x80\x935595.</span> [<a href="/pubmed/3106339" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Genistein,+a+specific+inhibitor+of+tyrosine-specific+protein+kinases&amp;author=T+Akiyama&amp;author=J+Ishida&amp;author=S+Nakagawa&amp;author=H+Ogawara&amp;author=S+Watanabe&amp;volume=262&amp;publication_year=1987&amp;pages=5592-5595&amp;pmid=3106339&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Kim HP, Son KH, Chang HW, Kang SS. Anti-inflammatory plant flavonoids and cellular action mechanisms. <span><span class="ref-journal">J Pharmacol Sci. </span>2004;<span class="ref-vol">96</span>:229\xe2\x80\x93245. doi: 10.1254/jphs.CRJ04003X.</span> [<a href="/pubmed/15539763" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1254%2Fjphs.CRJ04003X" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Sci&amp;title=Anti-inflammatory+plant+flavonoids+and+cellular+action+mechanisms&amp;author=HP+Kim&amp;author=KH+Son&amp;author=HW+Chang&amp;author=SS+Kang&amp;volume=96&amp;publication_year=2004&amp;pages=229-245&amp;pmid=15539763&amp;doi=10.1254/jphs.CRJ04003X&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Singh S, Natarajan K, Aggarwal BB. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. <span><span class="ref-journal">J Immunol. </span>1996;<span class="ref-vol">157</span>:4412\xe2\x80\x934420.</span> [<a href="/pubmed/8906816" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Capsaicin+(8-methyl-N-vanillyl-6-nonenamide)+is+a+potent+inhibitor+of+nuclear+transcription+factor-kappa+B+activation+by+diverse+agents&amp;author=S+Singh&amp;author=K+Natarajan&amp;author=BB+Aggarwal&amp;volume=157&amp;publication_year=1996&amp;pages=4412-4420&amp;pmid=8906816&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Geppetti P, Trevisani M. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. <span><span class="ref-journal">Br J Pharmacol. </span>2004;<span class="ref-vol">141</span>:1313\xe2\x80\x931320. doi: 10.1038/sj.bjp.0705768.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1574908/">PMC free article</a>]</span> [<a href="/pubmed/15051629" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fsj.bjp.0705768" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;title=Activation+and+sensitisation+of+the+vanilloid+receptor:+role+in+gastrointestinal+inflammation+and+function&amp;author=P+Geppetti&amp;author=M+Trevisani&amp;volume=141&amp;publication_year=2004&amp;pages=1313-1320&amp;pmid=15051629&amp;doi=10.1038/sj.bjp.0705768&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Mensah JL, Lagarde I, Ceschin C, Michel G, Gleye J, Fouraste I. Antibacterial activity of the leaves of Phyllanthus discoideus. <span><span class="ref-journal">J Ethnopharmacol. </span>1990;<span class="ref-vol">28</span>:129\xe2\x80\x93133. doi: 10.1016/0378-8741(90)90069-6.</span> [<a href="/pubmed/2156112" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0378-8741(90)90069-6" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Ethnopharmacol&amp;title=Antibacterial+activity+of+the+leaves+of+Phyllanthus+discoideus&amp;author=JL+Mensah&amp;author=I+Lagarde&amp;author=C+Ceschin&amp;author=G+Michel&amp;author=J+Gleye&amp;volume=28&amp;publication_year=1990&amp;pages=129-133&amp;pmid=2156112&amp;doi=10.1016/0378-8741(90)90069-6&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Weenen H, Nkunya MH, Bray DH, Mwasumbi LB, Kinabo LS, Kilimali VA, Wijnberg JB. Antimalarial compounds containing an alpha, beta-unsaturated carbonyl moiety from Tanzanian medicinal plants. <span><span class="ref-journal">Planta Med. </span>1990;<span class="ref-vol">56</span>:371\xe2\x80\x93373. doi: 10.1055/s-2006-960985.</span> [<a href="/pubmed/2236290" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1055%2Fs-2006-960985" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Planta+Med&amp;title=Antimalarial+compounds+containing+an+alpha,+beta-unsaturated+carbonyl+moiety+from+Tanzanian+medicinal+plants&amp;author=H+Weenen&amp;author=MH+Nkunya&amp;author=DH+Bray&amp;author=LB+Mwasumbi&amp;author=LS+Kinabo&amp;volume=56&amp;publication_year=1990&amp;pages=371-373&amp;pmid=2236290&amp;doi=10.1055/s-2006-960985&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Smith E, Williamson E, Zloh M, Gibbons S. Isopimaric acid from Pinus nigra shows activity against multidrug-resistant and EMRSA strains of Staphylococcus aureus. <span><span class="ref-journal">Phytother Res. </span>2005;<span class="ref-vol">19</span>:538\xe2\x80\x93542. doi: 10.1002/ptr.1711.</span> [<a href="/pubmed/16114093" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fptr.1711" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Phytother+Res&amp;title=Isopimaric+acid+from+Pinus+nigra+shows+activity+against+multidrug-resistant+and+EMRSA+strains+of+Staphylococcus+aureus&amp;author=E+Smith&amp;author=E+Williamson&amp;author=M+Zloh&amp;author=S+Gibbons&amp;volume=19&amp;publication_year=2005&amp;pages=538-542&amp;pmid=16114093&amp;doi=10.1002/ptr.1711&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Imaizumi Y, Sakamoto K, Yamada A, Hotta A, Ohya S, Muraki K, Uchiyama M, Ohwada T. Molecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit. <span><span class="ref-journal">Mol Pharmacol. </span>2002;<span class="ref-vol">62</span>:836\xe2\x80\x93846. doi: 10.1124/mol.62.4.836.</span> [<a href="/pubmed/12237330" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1124%2Fmol.62.4.836" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;title=Molecular+basis+of+pimarane+compounds+as+novel+activators+of+large-conductance+Ca(2+)-activated+K(+)+channel+alpha-subunit&amp;author=Y+Imaizumi&amp;author=K+Sakamoto&amp;author=A+Yamada&amp;author=A+Hotta&amp;author=S+Ohya&amp;volume=62&amp;publication_year=2002&amp;pages=836-846&amp;pmid=12237330&amp;doi=10.1124/mol.62.4.836&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Hehner SP, Hofmann TG, Droge W, Schmitz ML. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. <span><span class="ref-journal">J Immunol. </span>1999;<span class="ref-vol">163</span>:5617\xe2\x80\x935623.</span> [<a href="/pubmed/10553091" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=The+antiinflammatory+sesquiterpene+lactone+parthenolide+inhibits+NF-kappa+B+by+targeting+the+I+kappa+B+kinase+complex&amp;author=SP+Hehner&amp;author=TG+Hofmann&amp;author=W+Droge&amp;author=ML+Schmitz&amp;volume=163&amp;publication_year=1999&amp;pages=5617-5623&amp;pmid=10553091&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1564392&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1564392/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1564392/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1564392/pdf/12985_2006_Article_175.pdf">PDF (401K)</a></li> | <li><a href="#" data-citationid="PMC1564392" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1564392%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1564392%2F&amp;text=Natural%20products%20that%20reduce%20rotavirus%20infectivity%20identified%20by%20a%20cell-based%20moderate-throughput%20screening%20assay"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1564392%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="16948846" data-aiid="7095540" data-aid="1564392" data-iid="354810" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC1564392" data-md5="a87a39efaad756b34a40abc3993d0034"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:20:13-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1B9739E99A76110000000003970397&amp;ncbi_session=8A1B9739E99AD0C1_0919SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1564392%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1564392/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1B9739E99AD0C1_0919SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'